Humana Inc. (HUM) has a MoatMap StockRank of 88/100 based on Quality (56/100), Value (43/100), and Momentum (74/100) factor scores. The current signal is STRONG BUY. Humana is facing severe structural headwinds in its core Medicare Advantage business, including regulatory rate cuts and elevated medical loss ratios (MLRs), destroying near-term visibility.
Humana Inc. is a leading U.S. health and well-being company focused on integrated health care plans, particularly for Medicare and Medicaid beneficiaries. The company's extensive clinical care services and strong focus on value-based care models differentiate it in the competitive health insurance landscape. Humana's significant market share in the growing Medicare Advantage sector provides a stable and expanding revenue base.
| Price | $350.14 |
| Market Cap | $37.1B |
| P/E (TTM) | 37.33 |
| P/E (Forward) | 22.26 |
| Price/Book | 2.26 |
| Return on Equity | 6.3% |
| Debt/Equity | 77.07 |
| Gross Margin | 14.0% |
| Operating Margin | 4.7% |
| Revenue Growth | 23.5% |
| Dividend Yield | 1.0% |
| Free Cash Flow | $1.4B |
Humana Inc. operates in the Healthcare Plans industry, part of the Healthcare sector (United States).